A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Clinical trial NCT01223222 · COMPLETED

Trial details

NCT number: NCT01223222
Sponsor: Lytix Biopharma AS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gram-positive, Skin Infections Mild Eczema/Dermatoses Atopic Dermatitis

Start date: 2010-09-01
Primary completion: 2011-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.